Cargando…
Diabète et COVID-19
According to previous reports, diabetes seems to be associated with serious clinical events due to COVID-19. But is diabetes per se a risk factor of being infected by the virus? We discuss these points. Data about the antidiabetic drugs are scarce. Dipeptidylpeptidase-4 (DPP-4) is found as both a ce...
Autores principales: | Bouhanick, Béatrice, Cracowski, Jean-Luc, Faillie, Jean-Luc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194540/ https://www.ncbi.nlm.nih.gov/pubmed/33965234 http://dx.doi.org/10.1016/j.therap.2020.04.004 |
Ejemplares similares
-
Diabetes and COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020) -
DPP-4 inhibitors and severe course of illness in patients with COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2021) -
Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020) -
Drugs acting on renin angiotensin system and use in ill patients with COVID-19
por: Alexandre, Joachim, et al.
Publicado: (2020) -
Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)